Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, with the study history otherwise unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T15:26:17.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice about NIH website updates explains that federal agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.4%
    Check dated 2026-10-24T18:13:10.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T18:10:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the study record information remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T19:07:40.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision tag updated from v3.6.6 to v3.7.0, indicating a newer build of the study record history UI.
    Difference
    0.1%
    Check dated 2026-09-19T19:09:00.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.6.6, replacing the previous v3.6.5. This is a metadata/build label update in the study history display and does not alter the study content or functionality.
    Difference
    0.1%
    Check dated 2026-08-29T18:57:35.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.